FDA Grants ReCell® Expedited Access Pathway Designation
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, announced that the US FDA has ruled that the ReCell® Autologous Cell Harvesting Device...
Read More
